85
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes

, , , &
Pages 99-104 | Published online: 14 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kira Harris, Cassie Boland, Lisa Meade & Dawn Battise. (2018) Adjunctive therapy for glucose control in patients with type 1 diabetes. Diabetes, Metabolic Syndrome and Obesity 11, pages 159-173.
Read now

Articles from other publishers (5)

Diana Isaacs, Stephanie Yager, Marcie Parker, Lauren Wolfe, Jennifer Luxenburg & Sanela Lekic. (2018) Adjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 Diabetes. Annals of Pharmacotherapy 53:4, pages 371-384.
Crossref
Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang & Hongting Zheng. (2018) DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of Diabetes Research 2018, pages 1-10.
Crossref
Ewa Otto-Buczkowska & Natalia Jainta. (2017) Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?. International Journal of Endocrinology and Metabolism 16:1.
Crossref
Rita Mohan Dallumal, Siew Siang Chua, David Bin-Chia Wu & Shireene Ratna Vethakkan. (2015) Sitagliptin: Is It Effective in Routine Clinical Practice?. International Journal of Endocrinology 2015, pages 1-9.
Crossref
Hitomi ODA, Akihiro MORI, Peter LEE, Kaori SAEKI, Toshiro ARAI & Toshinori SAKO. (2014) Preliminary Study Characterizing the Use of Sitagliptin for Glycemic Control in Healthy Beagle Dogs with Normal Gluco-Homeostasis. Journal of Veterinary Medical Science 76:10, pages 1383-1387.
Crossref